US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ETF & Stock Investment

2,075.69

+17.030.83%

Number of Gainers:618

Number of Losers:389

Number of Flat:17

PE:- -

High:2,083.23

Open:2,058.90

Low:2,058.90

Close:2,058.66

Volume:6.00B

Turnover:741.53B

Market Cap:96.63T

Float Cap:90.45T

Loading ...

Regeneron Pharmaceuticals, - Ubamatamab Shows 73% Objective Response Rate and 11-Month Median Pfs in Lgsoc Patients

THOMSON REUTERS

Regeneron Pharmaceuticals, - Serious Teaes Grade 3+ in 21% of Lgsoc Patients; Traes in 74%; Neutropenia, Anemia, Elevated Liver Enzymes

THOMSON REUTERS

Regeneron Pharmaceuticals, - to Advance Ubamatamab into Confirmatory Phase 3 Trial for Lgsoc

THOMSON REUTERS

Ubamatamab (Muc16xcd3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (Lgsoc)

THOMSON REUTERS

Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)

AJ Bell Confirms Total Voting Rights and Share Capital Structure

Anglo American Executives Reinvest Interim Dividend in Company Shares

NAND Supply Tightness Could Persist Through 2028; Citi Bullish on AI-Driven Memory Chip Price Hikes, Reiterates Buy Rating on SanDisk (SNDK.US)

Walmart Stock Shines as Its App Helps Customers See the Light and the Peanut Butter

Regions Financial Price Target Cut to $27.00/Share from $31.00 by Evercore ISI Group

Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics

Regeneron Says Phase 2 Courage Trial Shows Trevogrumab Preserves Lean Mass During Semaglutide Weight Loss

GM Q2 U.S. Sales Fall 6% to 670,974 Vehicles Amid Smaller EV Market

Honda US Sales Rise 15.9% MoM in September to 121,796 Units, Bloomberg Reports

MT Newswires Live

Sogeclair Completes Sale of Airbus-Dedicated Engineering Activities to Akkodis

Accenture Shares Soar 22% as Fears Over AI Disruption to Business Fade

GM's Third-Quarter US Sales Fall

IDEXX Laboratories to Release Third-Quarter Results, Host Analyst Call

Regeneron Pharmaceuticals, - Lower Doses of Trevogrumab Well Tolerated with 77% Experiencing at Least One Adverse Event

THOMSON REUTERS

Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://hk.tigershowtime.com/stock/BK4585/news?page=137"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BK4585","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4585\",,,,,undefined,":{"symbol":"BK4585","market":"US","secType":"PLATE","nameCN":"ETF & Stock Investment","latestPrice":2075.6873,"timestamp":1790971199999,"preClose":2058.6597,"halted":0,"volume":6003625285,"delay":0,"changeRate":0.008271,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Not Yet Opened","change":17.027588,"latestTime":"10-02 16:00:00 EDT","open":2058.8958,"high":2083.2341,"low":2058.8958,"amount":741525952464.3318,"amplitude":0.011822,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1791207000000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":5.172671,"peRate":24.984808,"turnoverRate":0.010044,"increases":613,"decrements":393,"flats":11,"marketCap":96630096396846.62,"floatMarketCap":90452455333823.12},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4585\",,,,,undefined,":{"symbol":"BK4585","high":2083.2341,"amplitude":0.011822,"preClose":2058.6597,"low":2058.8958,"pbRate":"5.172671","latestPrice":2075.6873,"volume":6003625285,"delay":0,"open":2058.8958,"prevYearClose":1827.5802,"prevWeekClose":2075.6873,"prevMonthClose":2058.3613,"prevQuarterClose":2058.3613,"fiveDayClose":2079.4448,"twentyDayClose":2079.602,"sixtyDayClose":2026.3043,"secType":"PLATE","market":"US","turnoverRate":0.010044,"peRate":24.984808,"marketCap":96630096396846.62,"floatMarketCap":90452455333823.12,"timestamp":1790971199999,"nameCN":"ETF & Stock Investment"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4585\",,,,undefined,":{"bkCode":"BK4585","up":618,"down":389,"flat":17},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4585\",pageSize:20,pageCount:137,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2672653377","title":"Regeneron Pharmaceuticals, - Ubamatamab Shows 73% Objective Response Rate and 11-Month Median Pfs in Lgsoc Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2672653377","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672653377?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2324357040.USD","LU0823434583.USD","LU0058720904.USD","LU2362540622.SGD","LU2023250504.SGD","LU1917777945.USD","LU0320765992.SGD","LU0109394709.USD","IBB","BK4139","LU2362541273.HKD","LU2468319806.SGD","TBXU","LU0053666078.USD","LU2089984988.USD","LU0114720955.EUR","IBBQ","LU1974910355.USD","LU0289739699.SGD","LU2106854487.HKD","LU2362541513.USD","BK4588","LU0823434740.USD","LU0882574055.USD","LU0823416689.USD","BK4585","BBH","REGN","LU2237438978.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672653197","title":"Regeneron Pharmaceuticals, - Serious Teaes Grade 3+ in 21% of Lgsoc Patients; Traes in 74%; Neutropenia, Anemia, Elevated Liver Enzymes","url":"https://stock-news.laohu8.com/highlight/detail?id=2672653197","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672653197?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BBH","LU0823416689.USD","LU0889565916.HKD","LU2023250504.SGD","TBXU","REGN","BK4588","LU2362541513.USD","LU0114720955.EUR","LU2106854487.HKD","LU1917777945.USD","LU0882574055.USD","LU2324357040.USD","LU0823434740.USD","BK4139","LU0053666078.USD","LU2362540622.SGD","LU0823434583.USD","IBB","LU2089984988.USD","LU0058720904.USD","LU0320765992.SGD","IBBQ","LU1974910355.USD","LU2468319806.SGD","LU2362541273.HKD","LU2237438978.USD","LU0289739699.SGD","BK4585","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672314765","title":"Regeneron Pharmaceuticals, - to Advance Ubamatamab into Confirmatory Phase 3 Trial for Lgsoc","url":"https://stock-news.laohu8.com/highlight/detail?id=2672314765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672314765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:6","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0889565916.HKD","LU2237438978.USD","LU0823416689.USD","LU1974910355.USD","BBH","LU2468319806.SGD","LU2106854487.HKD","LU2023250504.SGD","LU0823434583.USD","BK4585","BK4588","REGN","IBB","LU2362541273.HKD","LU0289739699.SGD","LU0882574055.USD","LU0823434740.USD","LU1917777945.USD","IBBQ","LU0058720904.USD","LU0320765992.SGD","LU2324357040.USD","TBXU","BK4139","LU0114720955.EUR","LU2362541513.USD","LU2362540622.SGD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672176533","title":"Ubamatamab (Muc16xcd3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (Lgsoc)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672176533","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672176533?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA9RS104:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2106854487.HKD","IBB","LU0823416689.USD","LU0823434740.USD","BBH","LU1917777945.USD","LU2362541273.HKD","LU0114720955.EUR","LU0109394709.USD","LU2089984988.USD","LU2362540622.SGD","LU0053666078.USD","LU2468319806.SGD","LU2362541513.USD","TBXU","BK4588","LU0058720904.USD","LU2324357040.USD","LU0289739699.SGD","IBBQ","LU2023250504.SGD","LU0889565916.HKD","LU0320765992.SGD","REGN","BK4585","LU2237438978.USD","LU0823434583.USD","BK4139","LU1974910355.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765309","title":"Ubamatamab (MUC16xCD3) Shows a High Rate of Durable Responses in Initial Study of Patients with Advanced Low-Grade Serous Ovarian Cancer (LGSOC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765309","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765309?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:35","pubTimestamp":1790868900,"startTime":"0","endTime":"0","summary":"LGSOC is a biologically distinct variant of ovarian cancer, with limited treatment options, that is generally less responsive to conventional chemotherapy Results presented in a late-breaking plenary ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/10/01/3373161/0/en/ubamatamab-muc16xcd3-shows-a-high-rate-of-durable-responses-in-initial-study-of-patients-with-advanced-low-grade-serous-ovarian-cancer-lgsoc.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU2106854487.HKD","LU0889565916.HKD","LU2237438978.USD","IXJ","TBXU","LU2324357040.USD","IE00B19Z4B17.USD","LU2362541273.HKD","BK4104","LU0114720955.EUR","LU0823416689.USD","LU0320765992.SGD","IE0031619046.USD","LU0274383776.USD","IBBQ","LU2362540622.SGD","LU2931357623.SGD","VHT","CGCV","BK4157","BK4567","BK4550","LU2468319806.SGD","IE00B66KJ199.SGD","NOBL","LU0289739699.SGD","BBH","BK4585","LU0058720904.USD","BK4588","LU1974910355.USD","LU2023250504.SGD","LU2362541513.USD","BK4139","LU0823434583.USD","LU1815336091.USD","BCC","REGN","LU0109394709.USD","LU2089985449.USD","LU0757428866.USD","LU1917777945.USD","IBB","IE00B7SZL793.SGD","LU2089984988.USD","AEIS","LU0823434740.USD","LU0882574055.USD","TCAF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765540","title":"AJ Bell Confirms Total Voting Rights and Share Capital Structure","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765540","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765540?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:33","pubTimestamp":1790868831,"startTime":"0","endTime":"0","summary":"An announcement from AJ BELL PLC ( ($GB:AJB) ) is now available. AJ Bell PLC has confirmed that its issued share capital as of 30 September 2026 co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/aj-bell-confirms-total-voting-rights-and-share-capital-structure-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/aj-bell-confirms-total-voting-rights-and-share-capital-structure-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1267930227.SGD","LU0792757196.USD","BK4561","BK4566","IE00BYQQ9H92.USD","TSS","LU0889566641.SGD","STYL","LU0310800965.SGD","BK4581","LU0128525929.USD","LU0310800379.SGD","LU1267930573.SGD","LU0052756011.USD","BK4533","LU0823411888.USD","LU1303367103.USD","LU2098885051.SGD","LU1267930813.SGD","BK4534","LU0708994859.HKD","BK4588","IE00BFXG0V08.USD","LU0786609619.USD","BK4558","BK4146","BK4585","LU0128525689.USD","LU0029864427.USD","NKE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672576550","title":"Anglo American Executives Reinvest Interim Dividend in Company Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2672576550","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672576550?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:32","pubTimestamp":1790868778,"startTime":"0","endTime":"0","summary":"The latest update is out from Anglo American ( ($GB:AAL) ). Anglo American has disclosed a series of small share purchases by senior executives and...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/anglo-american-executives-reinvest-interim-dividend-in-company-shares?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/anglo-american-executives-reinvest-interim-dividend-in-company-shares?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4107","BK4547","BK4588","JETS","XTN","AAL","BK4585","AFG","BK4500","BK4008","BK4117","AALG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151556549","title":"NAND Supply Tightness Could Persist Through 2028; Citi Bullish on AI-Driven Memory Chip Price Hikes, Reiterates Buy Rating on SanDisk (SNDK.US)","url":"https://stock-news.laohu8.com/highlight/detail?id=1151556549","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1151556549?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:32","pubTimestamp":1790868747,"startTime":"0","endTime":"0","summary":"Citi Research stated that Micron Technology's (MU.US) latest fourth-quarter results further confirm the ongoing supply tightness in the NAND flash memory market, and the industry's tight...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130517989.USD","MUZ","LU1074936037.SGD","LU1244550221.USD","LU0648001328.SGD","MULL","MUD","AGIX","QTOC","LU0170899867.USD","LU0106831901.USD","LU1668664300.SGD","RAM","ARTY","LU2236285917.USD","LU2360032135.SGD","LU0203345920.USD","LU0098860793.USD","09747","LU1144417596.USD","CHAT","MUU","LU1366192091.USD","LU0072461881.USD","BK4504","BK4534","FTXO","IE00BSNM7G36.USD","BK4588","LU0320765646.SGD","LU1244550494.USD","AIPO","DRAM","BK4559","MIC","DISK","BK4207","TFNS","LU0128525689.USD","LU0477156953.USD","LU0162691827.USD","LU2417539215.USD","C","LU1162221912.USD","LU1201861249.SGD","LU2456880835.USD","LU2125154778.USD","RAMZ","LU0203347892.USD","MUYY","LU0310800965.SGD","LU1267930227.SGD","VTHR","IYF","LU1506573853.SGD","FTXL","DRAL","LU0130102774.USD","BK4585","DRMY","HBMX","LU1244550577.SGD","LU2125154935.USD","LU2462157665.USD","LU0052756011.USD","DRMP","BK4566","LU0980610538.SGD","MUG","LU0314106906.USD","LU1791807156.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672655877","title":"Walmart Stock Shines as Its App Helps Customers See the Light and the Peanut Butter","url":"https://stock-news.laohu8.com/highlight/detail?id=2672655877","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672655877?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:32","pubTimestamp":1790868737,"startTime":"0","endTime":"0","summary":"Walmart ($WMT) stock was brighter in early trading today after it said it was using its technology to help customers find the light – in its stores...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/walmart-stock-shines-as-its-app-helps-customers-see-the-light-and-the-peanut-butter?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/walmart-stock-shines-as-its-app-helps-customers-see-the-light-and-the-peanut-butter?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0096362180.USD","LU1035773651.USD","LU0265550359.USD","BK4504","LU2461242641.AUD","LU0238689110.USD","LU0256863902.USD","LU1804176565.USD","LU1814569148.SGD","LU2471134523.USD","LU0265550946.USD","LU0310799852.SGD","LU2471134952.CNY","LU1116320901.HKD","BK4588","LU2430703178.SGD","LU2750360997.AUD","LU1116320737.USD","LU2381873111.SGD","LU2087625088.SGD","LU0314104364.USD","LU2746668974.SGD","LU0353189680.USD","LU1585245621.USD","TRUO","LU1674673691.USD","LU2471134796.USD","LU2361045086.USD","BK4597","BK4585","LU2361044949.HKD","RTH","BK4532","LU2750360641.GBP","LU2097829019.USD","LU2471134879.HKD","LU2746668461.USD","IE0034235188.USD","LU1064131342.USD","LU2264538146.SGD","LU0061474960.USD","LU0353189763.USD","BK4155","LU2265009873.SGD","LU1066053197.SGD","LU0640476718.USD","LU1366192091.USD","LU2430703251.USD","LU0289960550.SGD","LU1069347547.HKD","LU2125154778.USD","LU1003077747.HKD","LU1066051811.HKD","LU1988902786.USD","LU0211327993.USD","BK4534","LU2125154935.USD","LU0553294199.USD","HK0000819398.USD","GB00BDT5M118.USD","LU1815333072.USD","WMT","LU2505996509.AUD","BK4550","LU0175139822.USD","LU0417517546.SGD","LU0211328371.USD","LU0545039389.USD","WMTI","UGE","BK4533","FSTA","XLP","LU0256863811.USD","LU1066051225.USD","LU2505996681.GBP","BK4581","LU2430703095.HKD","LU0738911758.USD","LU1267930490.SGD","LU0949170772.SGD","LU0661504455.SGD","LU2360032135.SGD","LU2592432038.USD","IE0001KFT4U8.USD","LU1280957306.USD","LU1430594728.SGD","LU0149725797.USD","LU1066051498.USD","LU1674673428.USD","LU2361044865.SGD","LU0957791311.USD","LU1778281490.HKD","IE000M9KFDE8.USD","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672658027","title":"Regions Financial Price Target Cut to $27.00/Share from $31.00 by Evercore ISI Group","url":"https://stock-news.laohu8.com/highlight/detail?id=2672658027","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672658027?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:32","pubTimestamp":1790868720,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/RF/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1880398554.USD","LU1883839398.USD","LU2596442595.SGD","BK4585","LU1880398471.USD","RF","BK4588","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672676557","title":"Eli Lilly (LLY) Ends Cancer Development Deal with Foghorn Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2672676557","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672676557?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868692,"startTime":"0","endTime":"0","summary":"Pharmaceutical giant Eli Lilly ($LLY) has ended a deal it had in place to develop cancer treatments with Foghorn Therapeutics ($FHTX). News of the ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/eli-lilly-lly-ends-cancer-development-deal-with-foghorn-therapeutics?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/eli-lilly-lly-ends-cancer-development-deal-with-foghorn-therapeutics?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BN29S564.USD","LU0174119429.USD","LU1291159041.SGD","LU2896262040.SGD","IXJ","LU2023250504.SGD","LU2023251221.USD","BK4588","IE00BFSS7M15.SGD","LU2111349929.HKD","SG9999015986.USD","LU2237443549.SGD","LU1988902786.USD","LU1548497426.USD","SGXZ81514606.USD","ELIL","LU1551013425.SGD","LU2461242641.AUD","LU1868836914.USD","LU2552382132.HKD","LU0787776722.HKD","BK4516","LU0096364046.USD","LU1868837136.USD","GDOC","LU2063271972.USD","IE0004445015.USD","SG9999013999.USD","LU0471298777.SGD","LU2271345857.HKD","LU2211815571.USD","LU0109391861.USD","LU0471298694.HKD","LU0820562030.AUD","LU2264538146.SGD","LU2265009873.SGD","LU0061475181.USD","LU1868836591.USD","LU2462157665.USD","IE00BK4W5L77.USD","LU2756315318.SGD","IE0009355771.USD","LLII","LU0238689110.USD","LU1093756168.USD","SGXZ99366536.SGD","LU2471134796.USD","LU1323610961.USD","LU1061106388.HKD","LU0320765992.SGD","LU2237443382.USD","SG9999018865.SGD","LU1366192091.USD","IE00BKPKM429.USD","LU2089283258.USD","LU0354030438.USD","LU2324357040.USD","SG9999018857.SGD","LU2361044865.SGD","GB00BDT5M118.USD","LU0225283273.USD","LU0210536198.USD","LU0203202063.USD","LU1035775433.USD","SGXZ31699556.SGD","LU1145028129.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU1720051017.SGD","LU0106261372.USD","BK4139","LU0708995401.HKD","IE00B775H168.HKD","LU2236285917.USD","WDNA","LU0882574055.USD","LU1064131342.USD","IE00BJLML261.HKD","LU2112291526.USD","LU2491050071.SGD","SG9999001176.SGD","SG9999014898.SGD","LU0345770993.USD","ELIS","HRTS","LLY","FHTX","LU0882574139.USD","MEDX","IE0001KFT4U8.USD","LU0114720955.EUR","LU1974910355.USD","LU2602419157.SGD","SG9999001176.USD","BK4533","CANC","LU2471134523.USD","SGXZ51526630.SGD","IE00BJJMRY28.SGD","LU1267930730.SGD","LU0385154629.USD","LU2237443895.HKD","BK4581","LU0823434583.USD","FTXH","LU0158827948.USD","IE00BK4W5M84.HKD","IE00B7KXQ091.USD","LU1712237335.SGD","SGXZ57979304.SGD","RXL","LLYZ","SG9999015978.USD","LU2028103732.USD","LU0006306889.USD","LU0345770308.USD","IE00B2B36J28.USD","JDOC","LU2023250330.USD","LU2168563687.JPY","LU2417539215.USD","LU2746668461.USD","PPH","LU1989771016.USD","MHIP","LU2468319806.SGD","LU0456855351.SGD","LU2213496289.HKD","LU2361045086.USD","LU0234572021.USD","BK4585","LLYX","ILDR","LU0466842654.USD","LU0079474960.USD","LU1623119135.USD","LU2456880835.USD","AGNG","LU1232071149.USD","LU2087625088.SGD","LU0316494557.USD","LU0353189680.USD","LU0786609619.USD","PJP","SG9999014914.USD","LU2168564222.USD","TRUH","LU0683600562.USD","CURE","LU0823416689.USD","FHLC","LU0266013472.USD","LU0640476718.USD","LU0964807845.USD","IE00BKDWB100.SGD","LU1720051108.HKD","IHE","IE0005OL40V9.USD","LU2089284900.SGD","LU1057294990.SGD","LU2360106947.USD","SG9999017495.SGD","IE00BWXC8680.SGD","LU0133085943.USD","SG9999014906.USD","BK4007","LU0320765059.SGD","LU0823434740.USD","LU2746668974.SGD","LU0943347566.SGD","LU1093756325.SGD","LU2491049909.HKD","LU2361044949.HKD","LU2108987350.USD","LU0323591593.USD","LU0097036916.USD","LU0198837287.USD","LU0672654240.SGD","IE00BFSS8Q28.SGD","BK4599","LU1069344957.HKD","LU1804176565.USD","LU1868836757.USD","LU2168564495.EUR","LU1551013342.USD","LU2756315664.SGD","LU2168564065.EUR","TMED","LU0203201768.USD","LU0820561818.USD","LU0889565916.HKD","LU0289739699.SGD","IE0004445239.USD","LU1868837300.USD","LU0820561909.HKD","LU2471134952.CNY","LU1691799644.USD","LU0109394709.USD","LU1127390331.HKD","IE00B1BXHZ80.USD","LU0094547139.USD","LU1023059063.AUD","IE00B1XK9C88.USD","SG9999015952.SGD","IE00B4JS1V06.HKD","LU0122379950.USD","LU1983299246.USD","MEDI","LU2750360997.AUD","LU2552382215.SGD","LU1629891620.HKD","LU2106854487.HKD","SG9999014880.SGD","XLV","LU2471134879.HKD","LU2552382058.USD","LU0256863811.USD","IYH","LU2237443978.SGD","LU1917777945.USD","LU2750360641.GBP","LU0353189763.USD","LU2237443465.HKD","LU2237438978.USD","LU0417517546.SGD","LU2237443622.USD","LU1979441026.SGD","LU2491050154.USD","IE0002141913.USD","IE00BJJMRX11.SGD","LU0058720904.USD","LU0432979614.USD","LU2357305700.SGD","LU2462591350.SGD","LU1814569148.SGD","IE00BJT1NW94.SGD","BK4534","OZEM","LU0256863902.USD","LU2089984988.USD","THNR","SG9999015945.SGD","VHT","IE00BJJMRZ35.SGD","LU0158827781.USD","LU1280957306.USD","LU0689472784.USD","LU2168564149.EUR","LU0354030511.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672813765","title":"Regeneron Says Phase 2 Courage Trial Shows Trevogrumab Preserves Lean Mass During Semaglutide Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2672813765","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672813765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868665,"startTime":"0","endTime":"0","summary":"Regeneron says Phase 2 COURAGE trial shows trevogrumab preserves lean mass during semaglutide weight lossRegeneron reported new Phase 2 COURAGE results showing trevogrumab helped preserve muscle durin","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL2GbBGj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BQXX3D17.EUR","IE00B64PRP62.GBP","LU1974910355.USD","LU2324357040.USD","BK4588","BK4139","BK4112","IE00BQXX3C00.GBP","BCDF","LU2362541513.USD","LU0882574055.USD","SG9999014039.USD","LU0109394709.USD","LU0823416689.USD","LU2210149790.SGD","LU0314104364.USD","SG9999014021.USD","IE00BGHQF748.EUR","BK4585","SG9999014005.SGD","LU2089984988.USD","TBXU","LU0823434583.USD","LU0320765992.SGD","IE00BN0W2T93.GBP","LU0889565916.HKD","LU2362541273.HKD","IBB","LU2468319806.SGD","IE00B3QW5Z07.USD","BBH","IE00BN0W2W23.USD","LU0053666078.USD","IE00BN0W2V16.EUR","LU0823434740.USD","LU0289739699.SGD","LU2023250504.SGD","NDAQ","LU2210150020.SGD","LU1917777945.USD","LU2362540622.SGD","SG9999014013.SGD","LU2237438978.USD","LU0058720904.USD","IE00BQXX3F31.USD","LU2106854487.HKD","IBBQ","LU2095319765.USD","LU0114720955.EUR","REGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765819","title":"GM Q2 U.S. Sales Fall 6% to 670,974 Vehicles Amid Smaller EV Market","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765819","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765819?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:31","pubTimestamp":1790868664,"startTime":"0","endTime":"0","summary":"GM Q2 U.S. sales fall 6% to 670,974 vehicles amid smaller EV marketGM reported Q2 U.S. sales of 670,974 vehicles, down 6%, citing a smaller EV market and discontinued models.Chevrolet Trax sales rose ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDL8wV3p:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B775SV38.USD","BK4561","GM","BK4566","BK4099","LU0208291251.USD","BK4559","LU0477156953.USD","LU2360107325.USD","LU0130518102.USD","LU0320765489.SGD","BK4555","LU0072461881.USD","LU0070302665.USD","LU0130103400.USD","LU1861219969.SGD","LU0130517989.USD","BK4516","LU0006061336.USD","IE00B3S45H60.SGD","LU1496350502.SGD","LU0648000940.SGD","BK4585","LU1201861249.SGD","LU1861214812.USD","LU0345770993.USD","LU0648001328.SGD","LU0211331839.USD","LU0477156797.USD","LU0980610538.SGD","LU0345770308.USD","LU1201861165.SGD","BK4588","LU0162691827.USD","LU0130102774.USD","BK4574","BK4596"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765839","title":"Honda US Sales Rise 15.9% MoM in September to 121,796 Units, Bloomberg Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765839","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765839?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868637,"startTime":"0","endTime":"0","summary":"Price: 31.58, Change: -0.03, Percent Change: -0.08","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4585","BK4588","HMC","BK4555","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672876583","title":"Sogeclair Completes Sale of Airbus-Dedicated Engineering Activities to Akkodis","url":"https://stock-news.laohu8.com/highlight/detail?id=2672876583","media":"Reuters","labels":["corporation","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672876583?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868634,"startTime":"0","endTime":"0","summary":"Sogeclair completes sale of Airbus-dedicated engineering activities to AkkodisSogeclair completed the sale of its Airbus-dedicated engineering activities to Akkodis.The perimeter covers 366 employees ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLdv518:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Sogeclair Completes Sale of Airbus-Dedicated Engineering Activities to Akkodis","news_tag":"corporation,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","IE00BN0W2W23.USD","IE00BQXX3F31.USD","LU2095319765.USD","LU2210149790.SGD","IE00BQXX3C00.GBP","SG9999014021.USD","IE00B3QW5Z07.USD","LU2210150020.SGD","BCDF","BK4585","SG9999014005.SGD","SG9999014013.SGD","IE00BGHQF748.EUR","IE00BN0W2T93.GBP","NDAQ","BK4112","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","IE00B64PRP62.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162157182","title":"Accenture Shares Soar 22% as Fears Over AI Disruption to Business Fade","url":"https://stock-news.laohu8.com/highlight/detail?id=1162157182","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162157182?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868627,"startTime":"0","endTime":"0","summary":"Accenture, the world's largest publicly listed consulting group, said its revenue growth is expected to accelerate this year, easing market concerns that artificial intelligence would destroy demand...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B7KXQ091.USD","IE00BJJMRY28.SGD","LU0545562505.USD","BK4534","LU1894683264.USD","LU0157215616.USD","LU0661504455.SGD","LU0289961442.SGD","BK4581","LU0289960550.SGD","HK0000819398.USD","LU1228905540.USD","IE00BFSS8Q28.SGD","LU0511384066.AUD","LU1228905037.USD","LU2133065610.SGD","IE0004445015.USD","SGXZ31699556.SGD","ACN","LU0553294199.USD","LU0175139822.USD","SG9999014898.SGD","LU2596442595.SGD","LU1823568750.SGD","LU1585245621.USD","BK4588","LU0265550946.USD","LU0942090050.USD","LU0738911758.USD","BK4585","LU0545039389.USD","SG9999018857.SGD","LU0323239441.USD","LU1366333091.USD","LU0868494617.USD","LU0342679015.USD","LU1506573853.SGD","VTHR","LU1235294995.USD","IE00BJJMRX11.SGD","LU1046421795.USD","CHAT","SG9999014906.USD","BK4561","LU0265550359.USD","LU2381873111.SGD","LU0149725797.USD","SG9999018865.SGD","QTOC","SG9999017495.SGD","AGIX","LU1003077747.HKD","IE000M9KFDE8.USD","LU1032466523.USD","LU1116320737.USD","LU1989772840.SGD","LU2211815571.USD","SG9999014914.USD","LU0868494708.USD","LU0323240290.USD","LU1989772923.USD","IE00BHPRN162.USD","IE00BFSS7M15.SGD","LU1894683348.USD","SG9999004303.SGD","SG9999014880.SGD","BK4566","LU0949170772.SGD","LU0081259029.USD","LU1430594728.SGD","AIPO","LU0289739343.SGD","BK4134","LU1883839398.USD","LU2247934214.USD","IE00BSNM7G36.USD","BK4533","SGXZ23171101.USD","ARTY","LU1116320901.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672765835","title":"GM's Third-Quarter US Sales Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2672765835","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672765835?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868622,"startTime":"0","endTime":"0","summary":"GM's third-quarter US sales fallOct 1 (Reuters)-General MotorsGM.Nreported a drop in third-quarter US sales on Thursday, as high gasoline prices weigh on demand for new vehicles.The company's overall quarterly sales fell 5.5% to 670,974 units, from 710,347 units a year earlier.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nL4N45N15J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4566","LU1201861165.SGD","IE00B775SV38.USD","LU0345770308.USD","BK4559","BK4574","LU0320765489.SGD","LU0648000940.SGD","LU0345770993.USD","LU0211331839.USD","BK4561","GM","LU0130518102.USD","LU0477156797.USD","LU1861219969.SGD","LU0130103400.USD","LU1496350502.SGD","LU0006061336.USD","LU0648001328.SGD","BK4596","LU1861214812.USD","LU0980610538.SGD","LU1201861249.SGD","BK4588","LU0130517989.USD","LU0477156953.USD","BK4099","LU0208291251.USD","LU0162691827.USD","LU0070302665.USD","IE00B3S45H60.SGD","BK4585","LU0072461881.USD","LU2360107325.USD","BK4516","LU0130102774.USD","BK4555"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672658367","title":"IDEXX Laboratories to Release Third-Quarter Results, Host Analyst Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2672658367","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672658367?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868615,"startTime":"0","endTime":"0","summary":"IDEXX Laboratories to release third-quarter results, host analyst callIDEXX Laboratories schedules release of Q3 2026 financial results for Monday, Nov. 2, 2026, before the market opens.Analyst confer","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nNDLbS7dQR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0345774631.USD","BK4588","LU0345774391.USD","LU2404859741.USD","GB00B4LPDJ14.GBP","LU0170899867.USD","IDXX","BK4585","LU1989771016.USD","LU1291159041.SGD","LU0690374961.EUR","LU1941712348.USD","LU2404859667.USD","BK4504","PAWZ","BK4567","BK4082","LU0690374615.EUR","GB00B4QBRK32.GBP","LU1941712264.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672888765","title":"Regeneron Pharmaceuticals, - Lower Doses of Trevogrumab Well Tolerated with 77% Experiencing at Least One Adverse Event","url":"https://stock-news.laohu8.com/highlight/detail?id=2672888765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672888765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0823434740.USD","TBXU","LU2468319806.SGD","LU2023250504.SGD","LU2362541513.USD","LU2106854487.HKD","LU2089984988.USD","BK4585","LU0114720955.EUR","BK4139","LU0882574055.USD","IBBQ","LU0823434583.USD","LU0823416689.USD","LU0289739699.SGD","LU0889565916.HKD","LU0053666078.USD","LU1917777945.USD","IBB","LU0058720904.USD","LU2362541273.HKD","BK4588","LU2324357040.USD","BBH","LU1974910355.USD","LU2237438978.USD","REGN","LU2362540622.SGD","LU0320765992.SGD","LU0109394709.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672884765","title":"Regeneron Pharmaceuticals, - Plans Phase 2 Trial of Trevogrumab with Glp-1 Therapies in Older Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=2672884765","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672884765?lang=en_us&edition=fundamental","pubTime":"2026-10-01 23:30","pubTimestamp":1790868600,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261001:nTUA5R1YTR:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2362541513.USD","LU0114720955.EUR","IBBQ","LU0823434740.USD","LU0109394709.USD","LU1974910355.USD","LU0823434583.USD","LU0882574055.USD","BBH","LU2362541273.HKD","LU2089984988.USD","IBB","BK4588","LU2106854487.HKD","LU0320765992.SGD","LU2468319806.SGD","LU1917777945.USD","LU2023250504.SGD","LU2324357040.USD","LU0289739699.SGD","REGN","LU2362540622.SGD","BK4585","TBXU","LU2237438978.USD","LU0823416689.USD","LU0889565916.HKD","BK4139","LU0053666078.USD","LU0058720904.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":910,"pageCount":137,"totalSize":18198,"code":"91000000","status":"200"}]}}